Related Experiment Video
Updated: Jun 11, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
Dietary antioxidants improve arteriogenic erectile dysfunction.
Q Zhang1, Z M Radisavljevic, M B Siroky
1Department of Urology, VA Boston Healthcare System and Boston University School of Medicine, Boston, MA, USA.
Oxidative stress contributes to erectile dysfunction (ED). Pomegranate extract improved some ED markers in rabbits by reducing oxidative damage, but did not fully restore function.
Area of Science:
- Urology
- Cardiovascular Research
- Oxidative Stress Research
Background:
- Erectile dysfunction (ED) is frequently linked to oxidative stress risk factors like diabetes, smoking, and hypertension.
- Arterial atherosclerosis is a significant cause of ED, leading to impaired blood flow and tissue damage.
Purpose of the Study:
- To identify oxidative stress markers in atherosclerosis-induced ED.
- To evaluate the protective effects of dietary antioxidants, specifically pomegranate extract, on ED.
Main Methods:
- Rabbits with atherosclerosis-induced ED were treated with pomegranate extract or placebo.
- Evaluated penile blood flow, erectile activity, tissue relaxation, oxidative products, gene expression (SOD, AR), and ultrastructure.
Main Results:
- Atherosclerosis caused ED, characterized by impaired relaxation, fibrosis, increased oxidative products, and structural damage.
- Pomegranate extract improved blood flow, erectile activity, and reduced oxidative stress markers and structural damage compared to placebo.
- Antioxidant enzymes (SOD, AR) upregulation did not fully protect against oxidative injury; pomegranate extract was more effective at the molecular and ultrastructural level.
Conclusions:
- Oxidative stress is present in ED.
- Dietary antioxidants like pomegranate extract show promise in mitigating molecular and ultrastructural damage associated with ED.
- Antioxidants may be more effective in preventing damage than in fully restoring function in established ED.
Related Concept Videos
Atherosclerosis III: Management
Antihypertensive Drugs: Vasodilators
Coronary Artery Disease I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Coronary Artery Disease II: Pathophysiology
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
